These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4760050)

  • 1. Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus.
    Owens D; Srivastava MC; Tompkins CV; Nabarro JD; Sönksen PH
    Eur J Clin Invest; 1973 Jul; 3(4):284-94. PubMed ID: 4760050
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic responses to monocomponent human insulin infusions in normal subjects and patients with liver and endocrine disease.
    West TE; Owens D; Sönksen PH; Srivastava MC; Tompkins CV; Nabarro JD
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):573-84. PubMed ID: 1104216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic clearance and production rates of human growth hormone.
    Taylor AL; Finster JL; Mintz DH
    J Clin Invest; 1969 Dec; 48(12):2349-58. PubMed ID: 5355346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disappearance of labelled human growth hormone from the forearm circulation in normal and diabetic subjects.
    Boucher BJ; Butterfield WJ; Whichelow MJ
    Clin Sci; 1969 Dec; 37(3):721-30. PubMed ID: 5363567
    [No Abstract]   [Full Text] [Related]  

  • 5. The half-life of 131 I-insulin in different groups of patients compared with normal subjects.
    van Rooyen RJ; de Bruin EJ; Bieler EU; Hoog JM
    S Afr Med J; 1972 Dec; 46(49):1927-31. PubMed ID: 4631796
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics with clinical diabetic nephropathy.
    Hanssen KF; Svendsen PA; Evrin PE
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):75-86. PubMed ID: 4406483
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose tolerance, insulin, and growth hormone in thyrotoxicosis and in myxedema.
    Ohlsen PM; Danowski TS; Vidalon C; Ahmad U; Nolan S; Stephan T
    Endocr Res Commun; 1974; 1(5-6):435-48. PubMed ID: 4461267
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Nerup J; Koch C
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):217-23. PubMed ID: 7923827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of insulin-I-131 metabolism in the blood of diabetic patients].
    Yokoyama T
    Nihon Naibunpi Gakkai Zasshi; 1965 Nov; 41(8):969-82. PubMed ID: 5329933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parallel study of thyroxine and triiodo-thyronine metabolism in diabetics].
    Jaffiol C; Pastorello R; Cartry E; Mirouze J
    Ann Endocrinol (Paris); 1966; 27(6):703-18. PubMed ID: 4166140
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients.
    Jørgensen JO; Flyvbjerg A; Christiansen JS
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):8-13. PubMed ID: 2911943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.
    Hernandez A; Zorrilla E; Gershberg H
    J Lab Clin Med; 1969 Jan; 73(1):25-33. PubMed ID: 5762161
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic clearance of human growth hormone in patients with hepatic and renal failure, and in the isolated perfused pig liver.
    Cameron DP; Burger HG; Catt KJ; Gordon E; Watts JM
    Metabolism; 1972 Oct; 21(10):895-904. PubMed ID: 5071956
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth.
    MacGillivray MH; Frohman LA; Doe J
    J Clin Endocrinol Metab; 1970 May; 30(5):632-8. PubMed ID: 5444554
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin sensitivity in pancreatitis, liver diseases, steroid treatment and hyperthyroidism assessed by glucose, insulin and somatostatin infusion.
    Yasuda H; Harano Y; Ohgaku S; Kosugi K; Suzuki M; Hidaka H; Kashiwagi A; Shigeta Y
    Horm Metab Res; 1984 Jan; 16(1):3-6. PubMed ID: 6141989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics in relation to diabetic retinopathy.
    Hanssen KF
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):64-74. PubMed ID: 4406482
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin metabolism, insulin sensitivity and hormonal responses to insulin infusion in patients taking oral contraceptive steroids.
    Srivastava MC; Oakley NW; Tompkins CV; Sönksen PH; Wynn V
    Eur J Clin Invest; 1975 Sep; 5(5):425-33. PubMed ID: 1102319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of amino acids on the secretion of growth hormone and insulin in healthy persons and diabetics].
    Waldhäusl W; Beringer A
    Klin Wochenschr; 1969 Apr; 47(7):359-63. PubMed ID: 5383388
    [No Abstract]   [Full Text] [Related]  

  • 19. Vancomycin half-life in a patient with hepatic and renal dysfunction.
    Pachorek RE; Wood F
    Clin Pharm; 1991 Apr; 10(4):297-300. PubMed ID: 2032447
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of distribution in the metabolism of growth hormone in man.
    Srivastava MC; Owens D; Tompkins CV; Sönksen PH; Nabarro JD
    Biochem J; 1971 Dec; 125(3):64P-65P. PubMed ID: 5145877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.